Literature DB >> 21987298

Suppression of hath1 gene expression directly regulated by hes1 via notch signaling is associated with goblet cell depletion in ulcerative colitis.

Xiu Zheng1, Kiichiro Tsuchiya, Ryuichi Okamoto, Michiko Iwasaki, Yoshihito Kano, Naoya Sakamoto, Tetsuya Nakamura, Mamoru Watanabe.   

Abstract

BACKGROUND: The transcription factor Atoh1/Hath1 plays crucial roles in the differentiation program of human intestinal epithelium cells (IECs). Although previous studies have indicated that the Notch signal suppresses the differentiation program of IEC, the mechanism by which it does so remains unknown. This study shows that the undifferentiated state is maintained by the suppression of the Hath1 gene in human intestine.
METHODS: To assess the effect of Notch signaling, doxycycline-induced expression of Notch intracellular domain (NICD) and Hes1 cells were generated in LS174T. Hath1 gene expression was analyzed by quantitative reverse-transcription polymerase chain reaction (RT-PCR). Hath1 promoter region targeted by HES1 was determined by both reporter analysis and ChIP assay. Expression of Hath1 protein in ulcerative colitis (UC) was examined by immunohistochemistry.
RESULTS: Hath1 mRNA expression was increased by Notch signal inhibition. However, Hath1 expression was suppressed by ectopic HES1 expression alone even under Notch signal inhibition. Suppression of the Hath1 gene by Hes1, which binds to the 5' promoter region of Hath1, resulted in suppression of the phenotypic gene expression for goblet cells. In UC, the cooperation of aberrant expression of HES1 and the disappearance of caudal type homeobox 2 (CDX2) caused Hath1 suppression, resulting in goblet cell depletion.
CONCLUSIONS: The present study suggests that Hes1 is essential for Hath1 gene suppression via Notch signaling. Moreover, the suppression of Hath1 is associated with goblet cell depletion in UC. Understanding the regulation of goblet cell depletion may lead to the development of new therapy for UC.
Copyright © 2011 Crohn's & Colitis Foundation of America, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21987298     DOI: 10.1002/ibd.21611

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  49 in total

1.  Targeting Notch Signaling in Colorectal Cancer.

Authors:  Suman Suman; Trinath P Das; Murali K Ankem; Chendil Damodaran
Journal:  Curr Colorectal Cancer Rep       Date:  2014-12-01

Review 2.  ADAM Proteases and Gastrointestinal Function.

Authors:  Jennifer C Jones; Shelly Rustagi; Peter J Dempsey
Journal:  Annu Rev Physiol       Date:  2015-11-19       Impact factor: 19.318

Review 3.  Notch regulation of gastrointestinal stem cells.

Authors:  Elise S Demitrack; Linda C Samuelson
Journal:  J Physiol       Date:  2016-06-26       Impact factor: 5.182

Review 4.  Role of ADAM10 in intestinal crypt homeostasis and tumorigenesis.

Authors:  Peter J Dempsey
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2017-07-22       Impact factor: 4.739

Review 5.  Taking inflammatory bowel disease up a Notch.

Authors:  Lauren E Laitman; Stephanie Dahan
Journal:  Immunol Res       Date:  2012-12       Impact factor: 2.829

Review 6.  Major signaling pathways in intestinal stem cells.

Authors:  Tim Vanuytsel; Stefania Senger; Alessio Fasano; Terez Shea-Donohue
Journal:  Biochim Biophys Acta       Date:  2012-08-16

7.  Selection of cell fate in the organ of Corti involves the integration of Hes/Hey signaling at the Atoh1 promoter.

Authors:  Yassan Abdolazimi; Zlatka Stojanova; Neil Segil
Journal:  Development       Date:  2016-03-01       Impact factor: 6.868

8.  c-Jun N-terminal kinase 2 promotes enterocyte survival and goblet cell differentiation in the inflamed intestine.

Authors:  A D Mandić; E Bennek; J Verdier; K Zhang; S Roubrocks; R J Davis; B Denecke; N Gassler; K Streetz; A Kel; M Hornef; F J Cubero; C Trautwein; G Sellge
Journal:  Mucosal Immunol       Date:  2017-01-18       Impact factor: 7.313

9.  Implication of intestinal VDR deficiency in inflammatory bowel disease.

Authors:  Jung-Hwan Kim; Satoshi Yamaori; Tomotaka Tanabe; Caroline H Johnson; Kristopher W Krausz; Shigeaki Kato; Frank J Gonzalez
Journal:  Biochim Biophys Acta       Date:  2012-10-02

10.  Association of hepatocyte-derived growth factor receptor/caudal type homeobox 2 co-expression with mucosal regeneration in active ulcerative colitis.

Authors:  Ferenc Sipos; Miklós Constantinovits; Gábor Valcz; Zsolt Tulassay; Györgyi Műzes
Journal:  World J Gastroenterol       Date:  2015-07-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.